image
VistaGen Therapeutics, Inc. VTGN
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 2.55
0.394 %
$ 74.4 M
Market Cap
-1.53
P/E
Price Target Average
--100.00%
Revenue Forecast Estimate
381.11%
EBIT Estimate
--29.25%
Net Income Estimate
28.31%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets VistaGen Therapeutics, Inc.
image
VTGN has no price targets from Wall Street.
REVENUE FORECAST

Revenue Forecast Chart VTGN

image
$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)20172017202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart VTGN

image
$20.0m$20.0m$0.0$0.0($20.0m)($20.0m)($40.0m)($40.0m)($60.0m)($60.0m)($80.0m)($80.0m)($100.0m)($100.0m)($120.0m)($120.0m)($140.0m)($140.0m)($160.0m)($160.0m)20172017202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart VTGN

image
$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)($1.2b)($1.2b)20172017202120212022202220232023202420242025202520262026202720272028202820292029